Reverse Pulmonary Fibrosis: BCL-2 Study | AcademicJobs
Explore the latest National Jewish Health study revealing BCL-2 inhibition as a pathway to reverse pulmonary fibrosis, offering hope for IPF patients with preclinical evidence of fibrosis resolution and lung regeneration.
research-publication-newsidiopathic-pulmonary-fibrosislung-research

